Stocks and Investing Stocks and Investing
Tue, March 15, 2022
Mon, March 14, 2022
Fri, March 11, 2022
Thu, March 10, 2022

Kemp Dolliver Initiated (VRCA) at Strong Buy and Held Target at $20 on, Mar 10th, 2022


Published on 2024-10-27 20:01:38 - WOPRAI, Kemp Dolliver
  Print publication without navigation


Kemp Dolliver of Brookline Capital, Initiated "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy and Held Target at $20 on, Mar 10th, 2022.

Kemp has made no other calls on VRCA in the last 4 months.



There is 1 other peer that has a rating on VRCA. Out of the 1 peers that are also analyzing VRCA, 0 agree with Kemp's Rating of Hold.



This is the rating of the analyst that currently disagrees with Kemp


  • Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $18 on, Thursday, March 3rd, 2022